Click on one of these terms to refine your search
1 to 10 of 29 literature results
Recently, certain lots of heparin have been associated with an acute, rapid onset of serious side effects indicative of an allergic-type reaction. To …
Authors: Marco Guerrini, Daniela Beccati, Zachary Shriver, Annamaria Naggi, Karthik Viswanathan, Antonella Bisio, Ishan Capila, Jonathan C Lansing, Sara Guglieri, Blair Fraser,…
Source: Nature biotechnology. 2008 Jun
View Full TextRecently, certain batches of heparin have been associated with an acute, rapid onset of serious side-effects indicative of allergic-type reactions. Th…
Authors: Marco Guerrini, Zachary Shriver, Antonella Bisio, Annamaria Naggi, Benito Casu, Ram Sasisekharan, Giangiacomo Torri
Source: Thrombosis and haemostasis. 2009 Nov
View Full TextHeparanase is an endoglycosidase which cleaves heparan sulfate (HS) and hence participates in degradation and remodeling of the extracellular matrix (…
Authors: Israel Vlodavsky, Neta Ilan, Annamaria Naggi, Benito Casu
Source: Current pharmaceutical design. 2007
View Full TextAs part of a more extensive investigation on structural features of different low-molecular-weight heparins (LMWHs) that can affect their biological a…
Authors: Antonella Bisio, Davide Vecchietti, Laura Citterio, Marco Guerrini, Rahul Raman, Sabrina Bertini, Giorgio Eisele, Annamaria Naggi, Ram Sasisekharan, Giangiacomo Torri
Source: Thrombosis and haemostasis. 2009 Nov
View Full TextThe heparan sulfate proteoglycan syndecan-1 is expressed by myeloma cells and shed into the myeloma microenvironment. High levels of shed syndecan-1 i…
Authors: Yang Yang, Veronica MacLeod, Yuemeng Dai, Yekaterina Khotskaya-Sample, Zachary Shriver, Ganesh Venkataraman, Ram Sasisekharan, Annamaria Naggi, Giangiacomo Torri, Benito Casu,…
Source: Blood. 2007 Sep 15
View Free Full TextSemi-synthetic low-molecular-weight heparin samples (LMWHs), having homogeneous degree of polymerization and saccharide backbone, but differing in the…
Authors: Claudia Sissi, Lorena Lucatello, Annamaria Naggi, Giangiacomo Torri, Manlio Palumbo
Source: Biochemical pharmacology. 2006 Jan 12
View Full TextIndividual low molecular weight heparins (LMWHs) exhibit distinct pharmacological and biochemical profiles because of manufacturing differences. Corre…
Authors: Marco Guerrini, Sara Guglieri, Annamaria Naggi, Ram Sasisekharan, Giangiacomo Torri
Source: Seminars in thrombosis and hemostasis. 2007 Jul
View Full TextBiological and pharmacological interactions of heparin and structurally related glycosaminoglycans (GAGs) such as heparan sulfate (HS) involve complex…
Authors: Marco Guerrini, Annamaria Naggi, Sara Guglieri, Roberto Santarsiero, Giangiacomo Torri
Source: Analytical biochemistry. 2005 Feb 1
View Full TextVascular endothelial growth factor (VEGF) represents a target for antiangiogenic therapies in a wide spectrum of diseases, including cancer. As a nove…
Authors: Claudio Pisano, Concetta Aulicino, Loredana Vesci, Benito Casu, Annamaria Naggi, Giangiacomo Torri, Domenico Ribatti, Mirella Belleri, Marco Rusnati, Marco Presta
Source: Glycobiology. 2005 Feb
View Full TextHeparanase is an endo-beta-D-glucuronidase that cleaves the heparan sulfate chains of heparan sulfate proteoglycans and is implicated in angiogenesis …
Authors: Antonella Bisio, Alessandra Mantegazza, Elena Urso, Annamaria Naggi, Giangiacomo Torri, Christian Viskov, Benito Casu
Source: Seminars in thrombosis and hemostasis. 2007 Jul
View Full Text